无支架与有支架生物瓣行主动脉瓣置换术治疗主动脉瓣狭窄的比较
该研究纳入2007年至2018年因主动脉瓣狭窄行主动脉瓣置换术的1173例患者(无支架瓣559例、有支架瓣614例),并通过倾向性评分匹配生成348对。结果显示两组远期生存率与再手术累积发生率相近,无支架组5年跨瓣压差更低,作者推荐有支架瓣因其植入简便。
要点
- 倾向性评分匹配后两组10年生存率分别为59%与55%,差异无统计学显著(P = .20)。
- 因瓣膜退变再手术的10年累积发生率无支架组5.5%、有支架组4.7%(P = .25)。
- 5年随访跨瓣压差无支架组7 mm Hg低于有支架组11 mm Hg(P < .001)。
核心结论
- 有支架瓣与无支架瓣均可用于主动脉瓣狭窄的主动脉瓣置换术,作者推荐使用有支架瓣,原因是其植入简便。
研究设计与样本
- 2007年至2018年间单中心(原文未明确说明)连续行主动脉瓣置换术治疗主动脉瓣狭窄的1173例患者,其中无支架瓣559例、有支架瓣614例。
- 通过倾向性评分匹配年龄、性别、体表面积、二叶式主动脉瓣、慢性肺病、既往心脏手术、冠状动脉疾病、透析依赖的肾功能衰竭、瓣膜尺寸、同期手术和外科医生,生成348对匹配队列。
- 主要终点为远期生存与再手术发生率。
主要发现
- 总体手术死亡率为2.9%,无支架组与有支架组围手术期结果相似(P = .19)。
- 全队列与倾向性评分匹配队列中两组远期生存率相当,10年生存率无支架组59% vs 有支架组55%(P = .20)。
- 无支架瓣相较于有支架瓣的远期死亡风险HR为1.12(P = .33)。
- 因瓣膜退变再手术的10年累积发生率无支架组5.5% vs 有支架组4.7%(P = .25)。
- 5年随访跨瓣压差无支架组7 mm Hg vs 有支架组11 mm Hg,无支架组显著更低(P < .001)。
关键数值与推荐
- 倾向性评分匹配队列为348对。
- 总体手术死亡率2.9%(P = .19)。
- 10年生存率无支架组59% vs 有支架组55%(P = .20);无支架瓣对比有支架瓣远期死亡HR 1.12(P = .33)。
- 再手术10年累积发生率无支架组5.5% vs 有支架组4.7%(P = .25)。
- 5年跨瓣压差无支架组7 mm Hg vs 有支架组11 mm Hg(P < .001)。
临床怎么用
- 作者认为有支架瓣与无支架瓣均可用于主动脉瓣狭窄的主动脉瓣置换术,并推荐使用有支架瓣,原因是其植入简便。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The differences in long-term outcomes of aortic valve replacement for aortic stenosis between stentless and stented bioprostheses are controversial. METHODS: Between 2007 and 2018, 1173 patients underwent aortic valve replacement for aortic stenosis, including 559 treated with a stentless valve and 614 with a stented valve. A propensity score matched cohort with 348 pairs was generated by matching for age, sex, body surface area, bicuspid aortic valve, chronic lung disease, previous cardiac surgery, coronary artery disease, renal failure on dialysis, valve size, concomitant procedures, and surgeon. The primary endpoints of the study were long-term survival and incidence of reoperation. RESULTS: Immediate postoperative outcomes were similar between the stentless and stented groups with an overall operative mortality of 2.9% (P = .19). Kaplan-Meier estimation for long-term survival was comparable between the stentless and stented valves in both the whole cohort and the propensity score matched cohort (10-year survival 59% vs 55%, P = .20). The hazard ratio of stentless vs stented valve for risk of long-term mortality was 1.12 (P = .33). The 10-year cumulative incidence of reoperation due to valve degeneration was 5.5% in the stentless group and 4.7% in the stented group (P = .25). The transvalvular pressure gradient at 5-year follow-up was significantly lower in the stentless group (7 vs 11 mm Hg, P < .001). CONCLUSIONS: Both stented and stentless valves could be used in aortic valve replacement for aortic stenosis. We recommend stented valves for aortic valve replacement in patients with aortic stenosis for their simplicity of implantation.
引用
- Yang B, Makkinejad A, Fukuhara S, et al. Stentless Versus Stented Aortic Valve Replacement for Aortic Stenosis. Ann Thorac Surg. 2022. PMID: 35150616. doi:10.1016/j.athoracsur.2022.01.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。